---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/44760715.md"
description: "$Pfizer(PFE.US) dipped slightly, $Eli Lilly(LLY.US) was flat, while $SPDR S&P Biotech(XBI.US) actually saw a small gain. Big pharma has performed decently over the past month. $Eli Lilly(LLY.US) rose over 20% in the last 20 days, and $Pfizer(PFE.US) gained 9%, with defensive rotation capital staying put. On Tuesday, as tech rebounded, big pharma saw some capital outflow, while mid- and small-cap biotechs rallied alongside rising risk appetite. Will defensive funds rotate from big pharma to mid- and small-cap biotechs? I doubt a large-scale shift—$Eli Lilly(LLY.US) is driven by the certainty of weight-loss drugs, whereas smaller biotechs are betting on rate cuts and M&A; they're not chasing the same capital."
datetime: "2026-11-04T08:44:52.000Z"
locales:
  - [en](https://longbridge.com/en/topics/44760715.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/44760715.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/44760715.md)
author: "[Dimoo](https://longbridge.com/en/profiles/26968366.md)"
generator: "portal-rs"
---

# $Pfizer(PFE.US) dipped slightly, $Eli Lilly(LLY.US…


### Related Stocks

- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LLYX.US](https://longbridge.com/en/quote/LLYX.US.md)
- [ELIL.US](https://longbridge.com/en/quote/ELIL.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**